Here are some early-market movers for Wednesday.
Dearborn Bancorp, Inc. (NASDAQ: DEAR)
The financial services company which is the holding company for Fidelity Bank swung to a third-quarter profit reporting earnings of eight cents per share, up from a lost of $5.24 from the same period last year. Shares jumped 34.3% in pre-market trading.
Amylin Pharmaceuticals Inc. (NASDAQ: AMLN)
The FDA withheld approval for the Bydureon diabetes drug being developed in conjunction with Eli Lilly and Alkermes Inc. requesting further heart rate testing. Shares sank 48.6% in pre-market trading.
Alkermes Inc. (NASDAQ: ALKS)
The pharmaceutical company was also impacted by the FDA’s withholding of approval for the Bydureon diabetes drug with shares falling 24.7% in pre-market trading.
FSI International Inc (NASDAQ: FSII)
The microelectronics equipment manufacturer posted fourth-quarter results of 17 cents per share which beat analyst estimates of 15 cents per share. Despite the beat, shares were down 12% in pre-market trading after the company said it now expects to report a loss in the first quarter.
Cree Inc (NASDAQ: CREE)
Shares of the semiconductor company were down 9.8% in pre-market trading Wednesday after releasing mixed first-quarter results late Tuesday. The company reported non-GAAP earnings of 60 cents per share, beating estimates of 58 cents per share but revenue of $268.4 million fell short of the expected $277.6 million.
Tupperware Brands Corp. (NYSE: TUP)
The kitchen and home product manufacturer announced third-quarter results of earnings excluding items of 64 cents per share beating expectations of 58 cents per share. Shares were down 7.4% however, as the company narrowed its full year local currency sales growth outlook.